Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Taniguchi

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 10, 2006
[Insulin resistance]Nobuyuki Ura, Shinya Taniguchi
Journal of Gastroenterology|August 26, 2017
Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trialAtsushi Nakajima, Mitsunori Seki, Shinya Taniguchi
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|March 15, 2019
[Pharmacological characteristics and clinical study results of ileal bile acid transporter inhibitor elobixibat (GOOFICE<sup>®</sup> tablet 5 mg)]Naoki Ikeda, Shinya Taniguchi, Mitsunori Seki
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 10, 2006
[Molecular biology in regulation of kidney functions: Kallikrein-kinin system (bradykinin)]Hideaki Yoshida, Shinya Taniguchi, Nobuyuki Ura
Neurogastroenterology and Motility|August 22, 2018
Elobixibat, an ileal bile acid transporter inhibitor, induces giant migrating contractions during natural defecation in conscious dogsShinya Taniguchi, Tetsuo Yano, Masakazu Imaizumi, et al.
Biochimica Et Biophysica Acta|November 19, 2005
Proteolipid of vacuolar H(+)-ATPase of Plasmodium falciparum: cDNA cloning, gene organization and complementation of a yeast null mutantShouki Yatsushiro, Shinya Taniguchi, Toshihide Mitamura, et al.
Chemical Science|February 12, 2025
The role of cytosine methylation in regulating the topology and liquid-liquid phase separation of DNA G-quadruplexesMitsuki Tsuruta, Sumit Shil, Shinya Taniguchi, et al.
Neurogastroenterology and Motility|February 23, 2019
Efficacy, long-term safety, and impact on quality of life of elobixibat in more severe constipation: Post hoc analyses of two phase 3 trials in JapanAtsushi Nakajima, Shinya Taniguchi, Shinsuke Kurosu, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 10, 2007
Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzymeJun Agata, Nobuyuki Ura, Hideaki Yoshida, et al.
The Lancet. Gastroenterology & Hepatology|May 29, 2018
Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trialAtsushi Nakajima, Mitsunori Seki, Shinya Taniguchi, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 10, 2006
[Insulin resistance]Nobuyuki Ura, Shinya Taniguchi
Journal of Gastroenterology|August 26, 2017
Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trialAtsushi Nakajima, Mitsunori Seki, Shinya Taniguchi
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|March 15, 2019
[Pharmacological characteristics and clinical study results of ileal bile acid transporter inhibitor elobixibat (GOOFICE<sup>®</sup> tablet 5 mg)]Naoki Ikeda, Shinya Taniguchi, Mitsunori Seki
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 10, 2006
[Molecular biology in regulation of kidney functions: Kallikrein-kinin system (bradykinin)]Hideaki Yoshida, Shinya Taniguchi, Nobuyuki Ura
Neurogastroenterology and Motility|August 22, 2018
Elobixibat, an ileal bile acid transporter inhibitor, induces giant migrating contractions during natural defecation in conscious dogsShinya Taniguchi, Tetsuo Yano, Masakazu Imaizumi, et al.
Biochimica Et Biophysica Acta|November 19, 2005
Proteolipid of vacuolar H(+)-ATPase of Plasmodium falciparum: cDNA cloning, gene organization and complementation of a yeast null mutantShouki Yatsushiro, Shinya Taniguchi, Toshihide Mitamura, et al.
Chemical Science|February 12, 2025
The role of cytosine methylation in regulating the topology and liquid-liquid phase separation of DNA G-quadruplexesMitsuki Tsuruta, Sumit Shil, Shinya Taniguchi, et al.
Neurogastroenterology and Motility|February 23, 2019
Efficacy, long-term safety, and impact on quality of life of elobixibat in more severe constipation: Post hoc analyses of two phase 3 trials in JapanAtsushi Nakajima, Shinya Taniguchi, Shinsuke Kurosu, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 10, 2007
Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzymeJun Agata, Nobuyuki Ura, Hideaki Yoshida, et al.
The Lancet. Gastroenterology & Hepatology|May 29, 2018
Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trialAtsushi Nakajima, Mitsunori Seki, Shinya Taniguchi, et al.
Pageof 2